List of Tables
Table 1. Global Influenza Virus Nucleic Acid Test Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Influenza Virus Nucleic Acid Test Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Influenza Virus Nucleic Acid Test Kit Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Influenza Virus Nucleic Acid Test Kit Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Influenza Virus Nucleic Acid Test Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Influenza Virus Nucleic Acid Test Kit Sales by Region (2020-2025) & (K Units)
Table 8. Global Influenza Virus Nucleic Acid Test Kit Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Influenza Virus Nucleic Acid Test Kit Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Influenza Virus Nucleic Acid Test Kit Sales Share by Manufacturers (2020-2025)
Table 12. Global Influenza Virus Nucleic Acid Test Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Influenza Virus Nucleic Acid Test Kit Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Influenza Virus Nucleic Acid Test Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Nucleic Acid Test Kit as of 2024)
Table 16. Global Influenza Virus Nucleic Acid Test Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Influenza Virus Nucleic Acid Test Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Influenza Virus Nucleic Acid Test Kit Manufacturing Base and Headquarters
Table 19. Global Influenza Virus Nucleic Acid Test Kit Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Influenza Virus Nucleic Acid Test Kit Sales by Type (2020-2025) & (K Units)
Table 23. Global Influenza Virus Nucleic Acid Test Kit Sales by Type (2026-2031) & (K Units)
Table 24. Global Influenza Virus Nucleic Acid Test Kit Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Influenza Virus Nucleic Acid Test Kit Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Influenza Virus Nucleic Acid Test Kit ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Influenza Virus Nucleic Acid Test Kit Sales by Application (2020-2025) & (K Units)
Table 29. Global Influenza Virus Nucleic Acid Test Kit Sales by Application (2026-2031) & (K Units)
Table 30. Influenza Virus Nucleic Acid Test Kit High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Influenza Virus Nucleic Acid Test Kit Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Influenza Virus Nucleic Acid Test Kit Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Influenza Virus Nucleic Acid Test Kit ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Influenza Virus Nucleic Acid Test Kit Growth Accelerators and Market Barriers
Table 37. North America Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Influenza Virus Nucleic Acid Test Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Influenza Virus Nucleic Acid Test Kit Growth Accelerators and Market Barriers
Table 40. Europe Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Influenza Virus Nucleic Acid Test Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Growth Accelerators and Market Barriers
Table 45. Southeast Asia Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Influenza Virus Nucleic Acid Test Kit Investment Opportunities and Key Challenges
Table 47. Central and South America Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Influenza Virus Nucleic Acid Test Kit Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Influenza Virus Nucleic Acid Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Cepheid Corporation Information
Table 51. Cepheid Description and Major Businesses
Table 52. Cepheid Product Models, Descriptions and Specifications
Table 53. Cepheid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Cepheid Sales Value Proportion by Product in 2024
Table 55. Cepheid Sales Value Proportion by Application in 2024
Table 56. Cepheid Sales Value Proportion by Geographic Area in 2024
Table 57. Cepheid Influenza Virus Nucleic Acid Test Kit SWOT Analysis
Table 58. Cepheid Recent Developments
Table 59. Daan Gene Corporation Information
Table 60. Daan Gene Description and Major Businesses
Table 61. Daan Gene Product Models, Descriptions and Specifications
Table 62. Daan Gene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Daan Gene Sales Value Proportion by Product in 2024
Table 64. Daan Gene Sales Value Proportion by Application in 2024
Table 65. Daan Gene Sales Value Proportion by Geographic Area in 2024
Table 66. Daan Gene Influenza Virus Nucleic Acid Test Kit SWOT Analysis
Table 67. Daan Gene Recent Developments
Table 68. Shanghai Kehua Bio-Engineering Corporation Information
Table 69. Shanghai Kehua Bio-Engineering Description and Major Businesses
Table 70. Shanghai Kehua Bio-Engineering Product Models, Descriptions and Specifications
Table 71. Shanghai Kehua Bio-Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Shanghai Kehua Bio-Engineering Sales Value Proportion by Product in 2024
Table 73. Shanghai Kehua Bio-Engineering Sales Value Proportion by Application in 2024
Table 74. Shanghai Kehua Bio-Engineering Sales Value Proportion by Geographic Area in 2024
Table 75. Shanghai Kehua Bio-Engineering Influenza Virus Nucleic Acid Test Kit SWOT Analysis
Table 76. Shanghai Kehua Bio-Engineering Recent Developments
Table 77. Shanghai ZJ Bio-Tech Corporation Information
Table 78. Shanghai ZJ Bio-Tech Description and Major Businesses
Table 79. Shanghai ZJ Bio-Tech Product Models, Descriptions and Specifications
Table 80. Shanghai ZJ Bio-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Shanghai ZJ Bio-Tech Sales Value Proportion by Product in 2024
Table 82. Shanghai ZJ Bio-Tech Sales Value Proportion by Application in 2024
Table 83. Shanghai ZJ Bio-Tech Sales Value Proportion by Geographic Area in 2024
Table 84. Shanghai ZJ Bio-Tech Influenza Virus Nucleic Acid Test Kit SWOT Analysis
Table 85. Shanghai ZJ Bio-Tech Recent Developments
Table 86. Autobio Corporation Information
Table 87. Autobio Description and Major Businesses
Table 88. Autobio Product Models, Descriptions and Specifications
Table 89. Autobio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Autobio Sales Value Proportion by Product in 2024
Table 91. Autobio Sales Value Proportion by Application in 2024
Table 92. Autobio Sales Value Proportion by Geographic Area in 2024
Table 93. Autobio Influenza Virus Nucleic Acid Test Kit SWOT Analysis
Table 94. Autobio Recent Developments
Table 95. Sansure Biotech Corporation Information
Table 96. Sansure Biotech Description and Major Businesses
Table 97. Sansure Biotech Product Models, Descriptions and Specifications
Table 98. Sansure Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sansure Biotech Recent Developments
Table 100. Shanghai Rendu Biotechnology Corporation Information
Table 101. Shanghai Rendu Biotechnology Description and Major Businesses
Table 102. Shanghai Rendu Biotechnology Product Models, Descriptions and Specifications
Table 103. Shanghai Rendu Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai Rendu Biotechnology Recent Developments
Table 105. Key Raw Materials Distribution
Table 106. Raw Materials Key Suppliers
Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 108. Milestones in Production Technology Evolution
Table 109. Distributors List
Table 110. Market Trends and Market Evolution
Table 111. Market Drivers and Opportunities
Table 112. Market Challenges, Risks, and Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Virus Nucleic Acid Test Kit Product Picture
Figure 2. Global Influenza Virus Nucleic Acid Test Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Influenza A Product Picture
Figure 4. Influenza A/B Product Picture
Figure 5. Others Product Picture
Figure 6. Global Influenza Virus Nucleic Acid Test Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Lab
Figure 9. Others
Figure 10. Influenza Virus Nucleic Acid Test Kit Report Years Considered
Figure 11. Global Influenza Virus Nucleic Acid Test Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 13. Global Influenza Virus Nucleic Acid Test Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Influenza Virus Nucleic Acid Test Kit Revenue Market Share by Region (2020-2031)
Figure 15. Global Influenza Virus Nucleic Acid Test Kit Sales (2020-2031) & (K Units)
Figure 16. Global Influenza Virus Nucleic Acid Test Kit Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Influenza Virus Nucleic Acid Test Kit Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Influenza Virus Nucleic Acid Test Kit Sales Volume Market Share in 2024
Figure 19. Global Influenza Virus Nucleic Acid Test Kit Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Influenza A Revenue Market Share by Manufacturer in 2024
Figure 22. Influenza A/B Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Influenza Virus Nucleic Acid Test Kit Sales Market Share by Type (2020-2031)
Figure 25. Global Influenza Virus Nucleic Acid Test Kit Revenue Market Share by Type (2020-2031)
Figure 26. Global Influenza Virus Nucleic Acid Test Kit Sales Market Share by Application (2020-2031)
Figure 27. Global Influenza Virus Nucleic Acid Test Kit Revenue Market Share by Application (2020-2031)
Figure 28. North America Influenza Virus Nucleic Acid Test Kit Sales YoY (2020-2031) & (K Units)
Figure 29. North America Influenza Virus Nucleic Acid Test Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) in 2024
Figure 31. North America Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Influenza Virus Nucleic Acid Test Kit Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Influenza Virus Nucleic Acid Test Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) in 2024
Figure 41. Europe Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 46. France Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 61. India Influenza Virus Nucleic Acid Test Kit Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Influenza Virus Nucleic Acid Test Kit Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Influenza Virus Nucleic Acid Test Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Influenza Virus Nucleic Acid Test Kit Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Influenza Virus Nucleic Acid Test Kit Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Influenza Virus Nucleic Acid Test Kit Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Influenza Virus Nucleic Acid Test Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Influenza Virus Nucleic Acid Test Kit Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Influenza Virus Nucleic Acid Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Influenza Virus Nucleic Acid Test Kit Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Influenza Virus Nucleic Acid Test Kit Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Influenza Virus Nucleic Acid Test Kit Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Influenza Virus Nucleic Acid Test Kit Revenue (2020-2025) & (US$ Million)
Figure 82. Influenza Virus Nucleic Acid Test Kit Industry Chain Mapping
Figure 83. Regional Influenza Virus Nucleic Acid Test Kit Manufacturing Base Distribution (%)
Figure 84. Global Influenza Virus Nucleic Acid Test Kit Production Market Share by Region (2020-2031)
Figure 85. Influenza Virus Nucleic Acid Test Kit Production Process
Figure 86. Regional Influenza Virus Nucleic Acid Test Kit Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
